
Press Release|Articles|April 14, 2025
Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
Listen
0:00 / 0:00
Key Takeaways
- Lurasidone Hydrochloride Tablets treat schizophrenia in adults and adolescents aged 13 to 17 years.
- They address depressive episodes in Bipolar I Disorder for adults and pediatric patients aged 10 to 17.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Lurasidone Hydrochloride Tablets.
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of:
- Schizophrenia in adults and adolescents (13 to 17 years)
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
Lurasidone Hydrochloride Tablets in 20 mg, 40 mg, 60 mg, 80 mg, 120 mg strengths are available in 30-count bottles.
To find out more information on Lurasidone Hydrochloride Tablets, please visit:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
5




































































































































